Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Angel Investors in United Kingdom

Last updated: Apr 2024 A list of 50 angel investors that invest in Medical startups based in United kingdom. We rank investors based on the number of investments they made in Medical companies from United kingdom. We update this investor list every month.

Top 50 Medical Angel Investors in United Kingdom

Investor	Medical United Kingdom investments
Jonathan Milner	9
Ian Hogarth	3
Mark Bamforth	3
Matt Robinson	2
Michael Pennington	2
Taavet Hinrikus	2
Ariel Poler	2
Will Martin	2
Nicholas Edwards	2
Alexander Edward Chesterman	2
Matt Clifford	2
Jan Hruska	2
Will Brooks	2
Mark Cuban	1
Errol Damelin	1
Jim Breyer	1
Jonathan Lenson	1
Alex Macdonald	1
Johnathan Matlock	1
David Prior	1
David Evans	1
Tracy Doree	1
Maurice Ferre, M.D.	1
Bashar Hamood	1
Pa Nolan	1
Roger Hassan	1
Holly Branson	1
Bob Davis	1
Andrew MacKay	1
Henry Engelhardt	1
Elan Katz	1
Catherine Lenson	1
Robert Marshall	1
Jim Mellon	1
Sachin Agrawal	1
Paul Thandi	1
Carlos Gallardo	1
Reece Chowdhry	1
Imran Hakim	1
Peer Schatz	1
Stephen Bourke	1
Yusuf Hamied	1
Jon Moulton	1
Manny Kadre	1
Mark McCamish	1
Nicolaus Henke	1
Henry Carleton	1
Brendan O'Driscoll	1
Curtis Chambers	1
Brian Kennedy	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Canada

Portfolio highlights

Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
Pencil Biosciences — Next Generation Genome Editing Tool
Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Investment focus

Software, E-Commerce, Internet
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
Fabric — A file explorer and workspace for the internet age. Your drives, clouds, notes, screenshots, links and files automatically gathered into one intelligent home. The world's first AI-native universal storage.

Mark Bamforth is the Operating Partner at Ampersand Capital Partners.

Investment focus

Medical, Health Care, Biotechnology
Series A, Funding Round, Seed
United Kingdom, United States

Portfolio highlights

Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
PneumoWave — Empowering Intervention and Prevention for Opioid-Induced Respiratory Depression
Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.

Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.

Investment focus

Software, FinTech, Financial Services
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Kaedim — Kaedim’s product creates 3D content as easily as you can take a photo, 2D content, with your smartphone today.
Yonder — A modern lifestyle credit card packed with rewards, no foreign exchange fees, and loads more. Apply without needing a UK credit score.
Context.ai — Context.ai is product analytics for LLM applications. Understand your users and improve their experiences in your LLM powered products.

One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B. Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.

Investment focus

Software, SaaS, Financial Services
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Spain

Portfolio highlights

Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
FUEL — Where everlasting fanbases are built
Sidekick — Expertly-managed portfolios for the modern investor

Taavet Hinrikus is co-founder and CEO of TransferWise. Prior to starting TransferWise, Taavet was Skype’s director of strategy until 2008, starting as its first-ever employee. One of the World Economic Forum's Tech Pioneers, Taavet is an adviser to Prime Minister of Estonia on the digital agenda. He’s also a mentor and angel investor; hisinvestments include Tweetdeck, Mendeley, OMGPOP, Property Partner, Sunrise, Improbable and Mapillary.

Investment focus

FinTech, Financial Services, Software
Seed, Series A, Series B
United Kingdom, United States, Estonia

Portfolio highlights

Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
Open Cosmos — Driven by the vision of making space accessible to anyone, Open Cosmos provides simple and affordable space missions.Open Cosmos went from design to delivery of qb01, their first nanosatellite, in only four months, followed by a launch and deployment in LEO early April 2017. They are currently working with innovative payload developers towardsin-orbit demonstration and constellation deployment to enable services ranging from remote sensing to maritime domain awareness and machine-to-machine communications.
Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

Investment focus

Software, Social Media, Internet
Seed, Series A, Angel
United States, Mexico, United Kingdom

Portfolio highlights

Reloadly — Reloadly makes it easy for developers to connect with Mobile operator services. We are disrupting a Trillion dollar industry! Mobile Operators are stuck in old school business models, where most of the world is moving to open source platforms for developers to build amazing products. Reloadly is bridging the gap between mobile operators anddevelopers, and at the same time creating new sales channels for the 816 mobile operators around the world.
Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
humm — humm harnesses cutting-edge neuroscience into products that allow people to learn faster and perform better.humm is working to bring the incredible results of neuroscience research out of the lab and into non-invasive wearables that improve the quality of life for everyday people. Our first product is a clinically validated patch that you wearfor 15 minutes to get up to 90 minutes of improved working memory, by gently stimulating the signals in the part of the brain that controls your executive thinking. humm improves your ability to learn and be at your best, allowing people to reconnect with the joy of learning and challenge themselves to continue growing at any stage of life, whether it's for work or personal enjoyment!

Will Martin - Founder and Director @ Portfolio Ventures

Investment focus

FinTech, Financial Services, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Bequest — We're building a better way to protect you and your family, starting with personalised pay-as-you-go life insurance. Backed by Aviva.
Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Alex Chesterman is the founder and CEO of Cazoo. He was the Founder & CEO of ZPG Plc, a FTSE-250 listed company. Previously Alex co-founded Lovefilm, Europe's leading digital movie rental business, which was successfully sold to Amazon. Alex is also one of the UK's most active tech angel investors having backed dozens of early stagedigital startups and was awarded an OBE for services to services to digital entrepreneurship in 2016.

Investment focus

E-Commerce, FinTech, Financial Services
Seed, Pre-Seed, Series A
United Kingdom, France

Portfolio highlights

Lick — Lick | Paints, Wallpapers and Supplies. Your Room, Covered
Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
Vyne Technologies — Vyne Technologies is the specialist account-to-account payments platform.

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

Investment focus

Software, FinTech, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, India, United States

Portfolio highlights

Koos — KOOS is a simple legal and technological solution for motivating and rewarding your community. Boost your growth by sharing success.
Patch — Patch is your new neighbourhood space for work, community, and events.
Flow Engineering — Requirements management, made collaborative

Jan Hruska

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Will Brooks - Founder & Director @ Portfolio Ventures

Investment focus

Financial Services, FinTech, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Bequest — We're building a better way to protect you and your family, starting with personalised pay-as-you-go life insurance. Backed by Aviva.
Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Investment focus

Blockchain, Software, E-Commerce
Seed, Series A, Angel
United States, Vietnam, Singapore

Portfolio highlights

Bot-It — Online automation for everyone. Let Bot-It automatically complete your online tasks.
Allstar — Allstar is a gaming company that believes every gamer can become a content creator, with the right tools. The company is driven by its mission is to make the everyday gamer the star of their greatest esports moments through technology that enables them to effortlessly create, discover, and share their own professional quality esports highlights.
Glove Wrap — Glove Wrap is a latex-free, thermoplastic elastomer band with the precise thickness, width, and length required to break in and shape your complete baseball glove while making the ideal pocket. Wrapping your glove with Glove Wrap applies pressure to the glove, reshaping it for easy use.

Errol Damelin is the Founder, CEO, chairman, or original investor and backer of over 75 digital and tech companies around the world, including in the US, the UK, most of Europe, Israel, Indonesia, Brazil, Turkey, South Africa, and Nigeria. He concentrates his efforts on SaaS, fintech, crypto, marketplaces and data analytics as well as on health andwellness. He is also a technologist and has three granted patents to his name with another four pending.Among the companies co-founded by Damelin are groundbreaking fintech company Wonga, and SME banking startup Tide. His early investments include Wise, Cazoo, Purplebricks, K Health, YuLife, Sure, Demyst, Zoe, Farewill, CityMapper, Modifi, UnBabel, Thimble, HiBob, Modifi, Elliptic, Lendingkart, and VivaReal. Using his own personal equity, Damelin continues to invest early on in the next generation of entrepreneurs so that he can help them succeed. He is not an institutional VC fund and does not maximize the assets under his management. He best describes his approach as Riding Shotgun.Damelin's success as a founder has been recognized by The Guardian, which named him Digital Entrepreneur of the Year in 2011; by Ernst and Young, which named him the UK's Entrepreneur of the Year in 2011 as well; and by TechCrunch, which named him Founder of the Year in 2010.

Investment focus

FinTech, Financial Services, Finance
Seed, Series A, Pre-Seed
United Kingdom, United States, Israel

Portfolio highlights

Zelt — Manage everything from HRIS, payroll, pension, devices, apps and more seamlessly in one central hub, for all processes and applications, third-party included. Improve productivity through enhanced employee experience.
Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Ritual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback

Jim Breyer - Co-Founder @ Accel-KKR

Investment focus

Health Care, Information Technology, Artificial Intelligence
Series B, Series A, Series C
United States, United Kingdom, Singapore

Portfolio highlights

Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.

Jonathan Lenson

Investment focus

Software, Information Technology, Internet
Seed, Grant, Pre-Seed
United Kingdom, Israel

Portfolio highlights

Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
Roleshare — Roleshare matches freelancers, part-time and fractional workers to job share; helping companies retain and attract coveted skills and talent. Join us!
Surfboard — Surfboard; Simpler, smarter and fairer scheduling software for customer support teams at scale. Click to learn more about our WFM solution.

Alex Macdonald is the Co-Founder and CEO of sequel - an investment platform on a mission to help athletes build a legacy for their families and the world. He previously Co-Founded Velocity Black, raised more than $40m in funding, and which was successfully exited to US Bank Capital One in 2023. He is a serial angel investor having invested in 50early stage startups and funds.

Investment focus

Software, Artificial Intelligence, FinTech
Pre-Seed, Seed, Series A
United Kingdom, United States, France

Portfolio highlights

Harriet — Efficient, cost effective AI for HR that improves the employee experience. Get time back to focus on what counts and let Harriet do the rest | Harriet
Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
Atman Labs — Hi, welcome to Atman Labs. We're an applied AI R&D and product company in London building software to emulate human expertise across multiple commercial domains.

Johnathan Matlock is Co-Founder Science Angel Syndicate.

Investment focus

Medical, Robotics, Biopharma
Seed, Pre-Seed
United Kingdom

Portfolio highlights

Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.

David Prior is the former chair of the UK's National Health Service.

Investment focus

Wellness, Health Care
Seed
Belgium

Portfolio highlights

TORTUS AI — TORTUS is building OSLER, a next-generation AI assistant for healthcare. Join us in creating the future today.
Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.

Principal at Apax Digital.

Investment focus

Rental, Medical, Software
Series A, Series D, Series E
Israel, United Kingdom

Portfolio highlights

Guesty — Guesty simplifies the way property managers work.
MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.

Tracy Dorée is a Founding Partner Kindred Capital. Tracy Dorée is the Co-Founder of Fab UK and serves as its Chief Executive Officer. She serves as Senior Vice President of Merchandising & Design for Europe at Fab, Inc. Tracy Dorée serves as an Investment Manager at MMC VENTURES Ltd. She joined MMC VENTURES in 2008 and is a Member of Investmentteam. Tracy Dorée is responsible for sourcing and executing new investments and managing individual portfolio companies. Prior to this, she gained experience in investment banking at NM Rothschild and strategy consulting at Accenture. Tracy Dorée served as Non-Executive Director of Base79 Limited. She holds a M.A. in Mathematics (first) from Balliol College, Oxford University.

Investment focus

FinTech, Medical, Wellness
Seed, Pre-Seed
United Kingdom

Portfolio highlights

Dishpatch — Dispatch is a finish-at-home meal kit platform that claims to bring the best of London’s ‘world-beating’ food scene to homes across the UK
Nosso — Nosso is a mobile-based financial planning platform for the future of children.
The Lowdown — 39K Followers, 1,214 Following, 723 Posts - See Instagram photos and videos from The Lowdown (@get.the.lowdown)

Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in 2014.In June 2007, Dr. Ferré received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, he foundedVisualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until 2002 when the company was acquired by GE Healthcare, the healthcare division of the General Electric Company. Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare, until 2004.Dr. Ferré holds an M.D. and a Master’s degree in Public Health from Boston University.

Investment focus

Medical Device, Medical, Health Care
Series A, Seed, Angel
United States, United Kingdom

Portfolio highlights

Heru — Discover the future of vision care and virtual eye exams with Heru. Click to learn about our AR eye machines and virtual visual field exams.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
DermaSensor — We've built a handheld, objective device to assist primary care providers in evaluating skin lesions for the risk of cancer in seconds. Early detection saves lives.

Bashar Hamood is a result oriented professional with versatile experience across diverse organizational domains. He is well versed in the development of marketing strategies, branding, direct marketing, new products/brands launches, analysis, reporting, and positioning.He is an entrepreneur and self-starter with expansive experience in brandawareness and development, community outreach.Bashar is a versatile business manager with proven competencies in optimizing team dynamics uniting diverse agenda to common goal and harnessing strategic and operational drivers to deliver results.He has a strong analytical mind with rigorous study for each case and the output of each variation for each parameter.Bashar loves to take risk and new challenges.

Investment focus

Information Technology, Software, Mobile Apps
Seed, Pre-Seed, Angel
United States, India, United Arab Emirates

Portfolio highlights

Safedeploy — Fault free software update platform for tracking your software reliability in real time for every device and every software application
Event Arena — Event Arena organizes events, corporate events, conferences, sales promotions, and presentations.
Palacio Inc. — Palacio Inc. aims to inspire every living space through innovation in art and technology. Our first product Canvia is a revolutionary content platform for art and photography, which utilizes patented technology for a seamless and authentic experience in any environment. We bring content from leading contemporary creators and world class culturalinstitutions into our living spaces like never before.

Pa Nolan

Investment focus

Medical, Delivery, Shipping
Seed, Funding Round
Ireland, United Kingdom

Portfolio highlights

SiSaf — SiSaf delivers on the promise of RNA therapeutics with Bio-Courier technology.
Scurri — Scurri is next generation delivery management software that puts retailers back in control. Explore our delivery management software today.

Roger Hassan is the Founding Partner at Shorea Ventures.

Investment focus

Food and Beverage, Grocery, Medical
Seed, Angel, Pre-Seed
Germany, United Kingdom

Portfolio highlights

GetHalal — It's an online one-stop-shop for all Halal groceries, Halal fresh meat, fish, vegetables and fruits for all Muslims in Europe. We have multi-ordering channels, 24/7 customer support and offering 2nd-day delivery.
Tupu — Tupu engages in the manufacture and supply of mushroom-based foods.
getvoila — voilà is the Berlin-based company that enables people to enjoy fine dining experiences at home, with nationwide delivery.

Holly Branson

Investment focus

Medical, Incubators, Electronics
Seed, Angel
United Kingdom

Portfolio highlights

Denzel's —
mOm Incubators — mOm's mission is to provide global access to high-quality healthcare. The mOm incubator is compact, lightweight, robust and energy efficient infant incubator

Bob Davis is a General Partner at Highland Capital Partners and an Executive Chairman at Highland Transcend Partners. He was a CEO at Lycos. Bob attended Northeastern University and Babson College.

Investment focus

Internet, Advertising, Social Network
Series A, Series B, Series C
United States, United Kingdom

Portfolio highlights

LovePop — Buy online, personalize, schedule and send 3D pop-up cards with free shipping. Lovepop has greeting cards & paper art for every occasion. A Lovepop is a beautiful keepsake that unfolds like a miniature surprise.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Vecna Robotics — Vecna Robotics is the leading autonomous mobile robot (AMR) company that provides logistics automation and workflow optimization solutions.

Andrew MacKay

Investment focus

Medical, Hospital, Health Care
Seed
United Kingdom

Portfolio highlights

MyHealthPal — MyHealthPal is a health & wellbeing app to promote healthy living and help you manage your own or other people's health conditions.
Materials Nexus — Accelerating change to net-zero materials

Henry Engelhardt

Investment focus

Health Care, SaaS, Brewing
Series A, Funding Round, Debt Financing
United States, Australia, United Kingdom

Portfolio highlights

Proximie — Proximie enables healthcare organizations, surgeons, and medical device companies to improve patient safety, scale training efforts, and accelerate device adoption, all while driving substantial savings in cost and time.
UZURV — UZURV is the Adaptive Transportation Network Company serving individuals with disabilities, the elderly, and non-emergency medical transportation needs. It's the efficiency and convenience of rideshare coupled with credentialed, drug and alcohol tested drivers for safe, reliable mobility for the transportation disadvantaged. Our AdaptiveTransportation Network Company (TNC) offers door-to-door service, certified drivers, and driver selection options that provide a high level of care and encourage greater understanding and security between riders and drivers. We be the ADA is more than just a law. It's a Promise and in Mobility Independence for All.
Drop Bear Beer — Drop Bear Beer specializes in creating revolutionary craft beers. The company was founded in 2018 and is headquartered in Swansea, Wales.

Elan Katz, CEO at Quick RX.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Catherine is an investor, board director and executive coach. She is based in London and works globally.She is an experienced international C-suite executive with a strong track record in the People, DE&I and ESG fields. Together with Jonathan Lenson. she invests in exceptional early-stage tech companies across the UK, US and Israel, andbrings in-depth previous board experience as both an executive and non-executive director.She writes and speaks on topics including the future of work, corporate culture and purpose, diversity and inclusion, and work/life integration.As part of her coaching practice, she is the first UK-based facilitator to be certified in the Fair Play method. Catherine was the first female Managing Partner appointed at SoftBank Investment Advisers, the world’s largest technology investment firm with $175 billion under management in the two SoftBank Vision Funds and SoftBank Latin America Funds. As the founding Chief People Officer for five years (2017-2022), she led the HR, ESG and Real Estate teams globally.An experienced and trusted executive coach at C-suite level, she worked with companies within the Vision Fund portfolio on leadership, talent, DE&I, ESG, and operating challenges, including as a Board Director.Catherine built SBIA’s ESG practice and designed its strategy for Social Impact. She led SoftBank’s early stage venture funds focused on diverse founders, including the $100m+ SB Opportunity Fund (US) and Emerge (EMEA), including as an Investment Committee member.Catherine is a Young Global Leader of the World Economic Forum (Class of 2021) and a founding member of Sustainability30 (which brings together Chief Sustainability Officers from 30 of the world’s leading companies).She spent the formative years of her career at UBS AG, Switzerland’s leading financial services firm, and is proud to have progressed from intern to Managing Director in the same firm. In her final role there, she led Reward for UBS across the UK and EMEA region.

Investment focus

Software, Information Technology, Internet
Seed, Grant, Pre-Seed
United Kingdom, Israel

Portfolio highlights

Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
Roleshare — Roleshare matches freelancers, part-time and fractional workers to job share; helping companies retain and attract coveted skills and talent. Join us!
Surfboard — Surfboard; Simpler, smarter and fairer scheduling software for customer support teams at scale. Click to learn more about our WFM solution.

Robert Marshall is Executive Chairman of Martlet Capital.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.

Jim Mellon

Investment focus

Medical, Health Care, Pharmaceutical
Series A, Funding Round
United Kingdom

Portfolio highlights

Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.

Sachin Agrawal

Investment focus

Medical, Health Care, Health Diagnostics
Series A
United Kingdom

Portfolio highlights

Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.

Paul is the Founder and Chief Executive Officer of the NEC Group, the UK’s leading live events business, which owns; the NEC, ICC, Vox, Resorts World Arena, Utilita Arena Birmingham, The Ticket Factory and Amadeus.He was appointed Group CEO in 2006, bringing over 20 years’ experience in the media industry.Paul has since transformed the Groupinto a customer-centric and data-led organisation, whilst increasing its portfolio of businesses and venues, and leading the company through changes of ownership in 2015 and 2018.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.

Carlos Gallardo

Investment focus

Health Care, Medical Device, Medical
Seed, Series A
Spain, United Kingdom

Portfolio highlights

Amelia Virtual Care — Amelia, formerly Psious VR, is a Virtual Reality software for use by mental health professionals in their therapy sessions with over 100 available virtual environments.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Reece is the Founder & CEO of RLC Ventures - an early-stage SEIS/EIS VC fund investing in technology companies primarily focused on Fintech, Enterprise and Gaming. He was awarded “Top 5 Asian Tech Investors” 2018 (KPMG & Diversity UK) and is the youngest-ever investor to profiled by The Sunday Times. Reece is a frequent keynote andpanel speaker at prominent industry events such as StartupGrind Europe and Fintech Live. Reece holds a BA in International Business from Durham University and is a Chartered Management Consultant (ACMA, CGMA) having started his career as a Management Consultant at EY.Reece invests personally in all of RLC Ventures' investments.

Investment focus

Software, Financial Services, FinTech
Seed, Pre-Seed, Equity Crowdfunding
United Kingdom, Canada, United States

Portfolio highlights

Odin — Community and investment tools for people building the future.
Condense — Live-streamed volumetric video into game engines
Crowd Data Systems — Crowd Data Systems (CDS) offers a new approach to treasury management. CDS has developed an ‘app by app’ Treasury Management System which is built upon cloud infrastructure, offering everything from cash to exposure management in modular parts.

Imran Hakim, Optometrist, Inventor, and Serial Entrepreneur.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).

Investment focus

Medical, Genetics, Health Care
Seed
United States, United Kingdom

Portfolio highlights

Valar Labs — AI to Make Oncologists Smarter
Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.

Stephen Bourke

Investment focus

Health Care, Medical, Wellness
Pre-Seed, Angel
United Kingdom

Portfolio highlights

Jude — Hey, we're Jude. A healthcare start-up on a mission is to bring bladder care into the mainstream.
Habitual — Our diabetes remission programme combines digital therapeutics with diet and habit change. Our personalised programme delivers type 2 diabetes reversal and weight loss.
Syndi Health — Meet Syndi Health: an all-in-one platform for aggregating, recommending, and paying for digital health services - amplifying your employee wellbeing support with 0% admin.

Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.

Investment focus

Medical, Medical Device
Seed
United Kingdom

Portfolio highlights

1inhaler — 1inhaler operates as a developer of drug delivery device.

Jon Moulton is a British venture capitalist. He is the founder and managing partner of the private equity firm Better Capital, and is the former managing partner of the private equity firm Alchemy Partners.

Investment focus

Financial Services, FinTech, Banking
Funding Round, Seed, Series A
United Kingdom, Cyprus, Luxembourg

Portfolio highlights

Pockit — Open a prepaid account in 3 minutes online or in-app, get your contactless prepaid card in 2 working days with no credit check.
Hometree — Keep yourself warm with Hometree, and try our no price hike promise. Compare our different boiler & home cover plans to see how you can save.
Hellas Direct — Hellas Direct is a digital-first, full-stack insurance company, empowered by cutting-edge technology and artificial intelligence. The Cyprus-based company is backed by a roster of leading investors, including Portag3, IFC (a member of the World Bank), Endeavor Catalyst, former Goldman Sachs economist Lord O’Neill and private equity veteran JonMoulton. Modelling itself on Amazon, Hellas Direct aims to disrupt the insurance value chain by adopting an extreme focus on operational excellence.

Manny Kadre

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Dr. McCamish is President and Chief Executive Officer of IconOVir Bio. Previously he was President and Chief Executive Officer of Forty Seven, Inc. He led Forty Seven, Inc. during critical phases of clinical development to help patients defeat their cancer. This included growing from a valuation of $169 million as a private company through a SeriesB offering, Initial Public Offering, two secondary fund raises and finally the acquisition of Forty Seven by Gilead for $4.9 Billion.He is an international expert in biologic and biosimilars development and manufacturing. Mark is passionate about mentoring and developing people while focusing on meeting patient needs through efficient, commercially viable efforts. He is a senior executive with extensive experience at multiple companies including Abbott, Amgen, and Novartis/Sandoz. He led pioneering efforts in filing/launching biosimilars worldwide. He has demonstrated a commercial mindset in establishing research and development strategies leading to approvals and commercial success in multiple therapeutic areas and regulatory categories including biologics, biosimilars, drugs, devices, and medical foods.He received Bachelor’s and Master’s degrees from UCSB and, after completing his PhD in Human Nutrition from Penn State and MD from UCLA, he completed Residency and Fellowship Training at the University of California, Davis. He held professorships at UC Davis and The Ohio State University

Investment focus

Medical, Biopharma, Biotechnology
Seed
United Kingdom

Portfolio highlights

Nemesis Bioscience — Nemesis Bioscience is a UK-based biopharmaceutical company developing products to resurrect anti-microbial therapies made ineffective by increasing microbial resistance. The company develops Nemesis Symbiotics that will make existing antibiotics work again, prevent the spread of resistance genes, and so also protect the efficacy of new antibiotics.The technology is applicable to all antibiotic classes, all known resistance mechanisms and all bacteria.Other applications include reduction of chemotherapeutic toxicity, inactivation of virulence factors, and in vivo synthesis of biofuels and therapeutics.The company was awarded the King’s College, Cambridge Entrepreneurship Award for 2014 and has filed patent applications internationally on its inventions.

Nicolaus Henke is a senior partner at McKinsey & Company, where he advises leading companies on how to improve decision making and performance through advanced analytics, artificial intelligence, and end-to-end data enabled transformations, and is the global leader of McKinsey Analytics, which has more than 2,000 dedicated analyticspractitioners and translators, where he oversees partnerships between McKinsey and the wider artificial intelligence, data, and computing ecosystem. Nicolaus is the chairman of QuantumBlack (acquired by McKinsey in 2015), a company operating at the intersection of strategy, technology, and design, and a member of McKinsey’s global board, the Shareholder’s Council. He helped found and is a member of the Board of Innovative Healthcare Delivery at Duke Medicine and serves on the Dean’s Advisory Council at Harvard’s Kennedy School. Nicolaus frequently speaks on big data, analytics, and healthcare topics at global forums such as the World Economic Forum, the Milken Institute, and Forbes. He holds a master’s degree and PhD in business from the University of Münster, Germany, and a master’s in public administration from Harvard University, where he was a John J. McCloy Scholar.

Investment focus

Information Technology, SaaS, Medical
Seed, Pre-Seed
United Kingdom

Portfolio highlights

seedata.io — Using deception technology, our platform enables customers to deploy decoys quickly, automatically rotate them, and detect potential attackers early, reducing the chances of a security incident going unnoticed.
Little Journey — Little Journey supports children and their families before, during and after healthcare interactions, reducing anxiety and improving health outcomes
Oxford Medical Simulation — Drive clinical competency with OMS. Combining healthcare education and competency assessment with dynamic virtual reality simulations.

Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.

Investment focus

Medical, Health Care, Health Diagnostics
Series A
United Kingdom

Portfolio highlights

Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.

Brendan O'Driscoll is the Chief Product Officer of KOHO.

Investment focus

Health Care, Wellness, Artificial Intelligence
Seed, Pre-Seed, Series A
United States, India, United Kingdom

Portfolio highlights

Betterhalf — Best matrimony app in India with AI matchmaking. Get compatible life partner from lakhs of genuine, Govt ID and selfie verified profiles of brides & grooms. Download Betterhalf marriage app now!
Betty Labs — Spotify is a digital music service that gives you access to millions of songs.
Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)

Curtis Chambers

Investment focus

Internet, GPS, Marketplace
Seed, Series A, Pre-Seed
United States, United Kingdom

Portfolio highlights

Nana — Nana is a vertically integrated student-to-operator trade skills school, today focused on Appliance Repair. We work with some of the 35 million people who will lose their jobs by 2030 to tech automation, teaching them trade skills, building their experience through our mentorship program, and connecting them to good jobs on our marketplace. Byperfecting this pipeline and teaching life skills to a new generation of tradespeople, we are accelerating the retooling of America’s workforce and creating millions of economic opportunities.
TruckMap — The routing and revenue platform for truck drivers.
Juggle Jobs — We help professionals work flexibly

Brian Kennedy

Investment focus

Music, Medical, Commercial
Angel, Funding Round
United States, United Kingdom

Portfolio highlights

Gigmor — Booking live music has never been this easy!
Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate